Skip to main content
Premium Trial:

Request an Annual Quote

Nalagenetics Gets CE Mark for PGx Software Module

NEW YORK — Singapore-based genetic testing software firm Nalagenetics said on Tuesday that it has received the CE mark for a reporting module for its flagship Clinical Decision Support (CDS) pharmacogenomics portal.

The module, called Nala CDS Module – PGx Core, is companion software for the company's research-use-only qPCR Nala PGx Core genotyping kit. The kit reads 20 variants within four genes — CYP2D6, CYP2C9, CYP2C19, and SLCO1B1 — and the software can generate over 170 drug-gene reports, Nalagenetics said.

"We are very excited about this milestone to build credibility in the European and home market in Southeast Asia," Nalagenetics CEO Levana Sani said in a statement. "With pharmacogenomics testing becoming more and more ubiquitous around the world, it requires standardized and robust tools to support the rapid increase of adoption."

In March, Nalagenetics closed a $12.6 million Series A financing round. About a month later, the firm partnered with MGI Tech to codevelop a low-coverage whole-genome sequencing workflow for risk prediction and pharmacogenomics.

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.